Why Novo Nordisk’s Drugs Are Anti-Obesity Game-Changers: CNBC Healthy Returns Summit 2023

Описание к видео Why Novo Nordisk’s Drugs Are Anti-Obesity Game-Changers: CNBC Healthy Returns Summit 2023

Lars Fruergaard Jørgensen, Novo Nordisk A/S President & CEO 
Karin Conde-Knape, Novo Nordisk Senior Vice President for Global Drug Discovery
Moderator: Meg Tirrell, CNBC Senior Health & Science Reporter 

More from the CNBC Events: https://bit.ly/40ZdNd1
Subscribe to the CNBC Events Marketing Newsletter here: https://cnb.cx/3nJqzht

Follow on Twitter:   / cnbcevents  
Follow on LinkedIn:   / cnbcevents  
#CNBC #healthcare

Комментарии

Информация по комментариям в разработке